Company intelligence / Profile preview

Callan Pharma Services

Tampa, Florida, United Statescallanpharma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Callan Pharma Services is a formulation development research laboratory specializing in innovative solutions for ophthalmic and injectable/parenteral drug products. The company offers expertise in lyophilization services, nanoparticle technologies, and proprietary polymer-based solubility enhancement platforms such as Apisolex. It partners with pharmaceutical companies to solve complex formulation challenges but does not appear to have its own clinical pipeline or marketed products[1][2].

Therapeutic areas: Ophthalmology
Modalities: Small moleculeNanoparticlePolymer-based drug delivery
Industry: Drug Discovery Services

Partnerships

Not publicly disclosed; partners with pharma/biotech clients on formulation projects

Beyond the preview

Go deeper on Callan Pharma Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Callan Pharma Services.

Explore the full profile